Abstract |
SN-38 (7-ethyl-10-hydroxycamptothecin) is the active metabolite of irinotecan, which is 100-to 1000-fold more cytotoxic than irinotecan. Nevertheless, extreme hydrophobicity of SN-38 has prevented its clinical use. One way of improving the solubility and stability of SN-38 is to formulate the drug into nanoparticles. Folic acid has been widely used as a targeting moiety for various anticancer drugs. For folate-receptor-targeted anticancer therapy, SN-38 nanoparticles were produced using poly-lactide-co-glycolide- polyethylene glycol- folate (PLGA-PEG-FOL) conjugate by emulsification/ solvent evaporation method. The FOL-conjugated di-block copolymer was synthesized by coupling the PLGA-PEG-NH(2) di-block copolymer with an activated folic acid. The conjugates were used for the formation of SN-38 nanoparticles with an average size of 200 nm in diameter. The SN-38 targeted nanoparticles showed a greater cytotoxicity against HT-29 cancer cells than SN-38 nontargeted nanoparticles. These results suggested that folate-targeted nanoparticles could be a potentially useful delivery system for SN-38 as an anticancer agent. FROM THE CLINICAL EDITOR:
SN-38 is the active metabolite of the chemotherapy agent irinotecan, which is 100-1000 fold more cytotoxic than irinotecan, but its extreme hydrophobicity has prevented its clinical use. In this paper, the authors present a nanotechnology-based approach targeting the folate-receptor with SN-38 loaded nanoparticles, demonstrating stronger cytotoxicity against HT-29 cancer cells than with control nanoparticles.
|
Authors | Pedram Ebrahimnejad, Rassoul Dinarvand, Abolghasem Sajadi, Mahmoud Reza Jaafari, Ali Reza Nomani, Ebrahim Azizi, Mazda Rad-Malekshahi, Fatemeh Atyabi |
Journal | Nanomedicine : nanotechnology, biology, and medicine
(Nanomedicine)
Vol. 6
Issue 3
Pg. 478-85
(Jun 2010)
ISSN: 1549-9642 [Electronic] United States |
PMID | 19836467
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Buffers
- Polylactic Acid-Polyglycolic Acid Copolymer
- Polyglycolic Acid
- Lactic Acid
- Polyethylene Glycols
- Irinotecan
- Folic Acid
- Camptothecin
|
Topics |
- Buffers
- Camptothecin
(analogs & derivatives, chemistry, pharmacology)
- Cell Death
(drug effects)
- Drug Delivery Systems
(methods)
- Folic Acid
(chemistry)
- HT29 Cells
- Humans
- Irinotecan
- Lactic Acid
(chemistry)
- Microscopy, Fluorescence
- Nanoparticles
(chemistry, ultrastructure)
- Polyethylene Glycols
(chemistry)
- Polyglycolic Acid
(chemistry)
- Polylactic Acid-Polyglycolic Acid Copolymer
|